Identification of a novel protein kinase Cδ-Smac complex that dissociates during paclitaxel-induced cell death

Katarzyna Chmielarska Masoumi1, Louise Cornmark, Gry Kalstad Lønne

  • 1Lund University, Center for Molecular Pathology, Skåne University Hospital, Malmö, Sweden.

FEBS Letters
|April 3, 2012
PubMed

Insights

Smac protein interacts with Protein Kinase C delta (PKCδ), a key regulator of programmed cell death (apoptosis). This interaction, disrupted by paclitaxel, is restored by PKCδ activation, preventing cell death.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of apoptosis
  • Signal transduction pathways

Background:

  • Protein Kinase C delta (PKCδ) plays a complex role in regulating apoptosis, with both pro- and anti-apoptotic functions.
  • The precise molecular mechanisms underlying these dual roles of PKCδ are not fully elucidated.

Purpose of the Study:

  • To investigate the interaction between Smac and PKCδ.
  • To elucidate the role of this interaction in paclitaxel-induced apoptosis.

Main Methods:

  • Co-immunoprecipitation assays to detect Smac-PKCδ interaction.
  • Western blotting to analyze protein localization and expression.
  • Cell viability assays to assess apoptosis.

Main Results:

  • Smac was found to interact with PKCδ, dependent on Smac's N-terminus.
  • Paclitaxel treatment disrupted the Smac-PKCδ interaction, leading to Smac release into the cytosol.
  • Activation of PKCδ rescued the interaction during paclitaxel exposure and suppressed paclitaxel-induced cell death.
  • The rescued complex was predominantly found in the cytosol, suggesting a role for cytosolic Smac binding by activated PKCδ.

Conclusions:

  • A novel interaction between Smac and PKCδ was identified.
  • PKCδ may exert its anti-apoptotic effects by binding to Smac, thereby preventing Smac's pro-apoptotic functions.
  • This interaction represents a new regulatory mechanism in apoptosis.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...